Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma — a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study)
✍ Scribed by Saburo Kawai; Jun Okamura; Makoto Ogawa; Yasuo Ohashi; Masayoshi Tani; Jushiro Inoue; Yoshifumi Kawarada; Mitsuo Kusano; Yasuhiko Kubo; Chikazumi Kuroda; Yu Sakata; Yoshiyuki Shimamura; Kenji Jinno; Akira Takahashi; Kenichi Takayasu; Kazuo Tamura; Naofumi Nagasue; Yoshimi Nakanishi; Masaoki Makino; Manabu Masuzawa; Shuichi Mikuriya; Morito Monden; Yasuhiro Yumoto; Takesada Mori; Toshitsugu Oda
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 553 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Transcatheter arterial chemoembolization is now widely used in cases of surgically unresectable hepatocellular carcinoma. However, it is unclear whether patients with surgically resectable hepatocellular carcinoma should always be treated with hepatectomy as opposed to transcatheter arterial chemoem